-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Studies have found that coloral cancer (CRC) can be driven by many genetic and epigenetic events simultaneously, with the third
At this stage, the guidelines of the National Comprehensive Cancer Network recommend MSI testing
Computed tomography (CT) is a common imaging method that plays an important role in CRC staging; However, for radiologists, assessing MSI status based on macroscopic CT images is quite a challenge
Recently, a study published in the European Journal of Radiology explored the diagnostic and prognostic stratification value of using CT-based radiomics methods in assessing MSI status, providing technical support
A total of 837 CRC patients
This study selected 10 features to construct a line plot that showed strong diagnostic performance in both internal and external validation queues, with area under the curve (AUC) of 0.
This study constructs and validates a non-invasive radioomics feature model based on conventional clinical CT images for MSI status recognition in CRC patients that can accurately stratify patients with stage II CRC and contribute to clinical decision-making
Original source:
Xiaobo Chen,Lan He,Qingshu Li,et al.